Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
about
Mechanisms of antimicrobial resistance in Gram-negative bacilli.Cefotaxime and Amoxicillin-Clavulanate Synergism against Extended-Spectrum-β-Lactamase-Producing Escherichia coli in a Murine Model of Urinary Tract Infection.High Emergence of ESBL-Producing E. coli Cystitis: Time to Get Smarter in CyprusHigh rates of multidrug resistance among uropathogenic Escherichia coli in children and analyses of ESBL producers from Nepal.Renal scar formation and kidney function following antibiotic-treated murine pyelonephritis.A Human Biofilm-Disrupting Monoclonal Antibody Potentiates Antibiotic Efficacy in Rodent Models of both Staphylococcus aureus and Acinetobacter baumannii Infections.Activity of temocillin in a lethal murine model of infection of intra-abdominal origin due to KPC-producing Escherichia coli.Prophylactic efficacy of cephamycin plus fluoroquinolones in high risk patients on inhibiting infectious complications after transrectal prostate biopsy.Cefoxitin as a carbapenem-sparing antibiotic for infections caused by extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.Activity of temocillin in a murine model of urinary tract infection due to Escherichia coli producing or not producing the ESBL CTX-M-15.Pharmacological study of cefoxitin as an alternative antibiotic therapy to carbapenems in treatment of urinary tract infections due to extended-spectrum-β-lactamase-producing Escherichia coli.
P2860
Q35935319-70EF2131-406C-44C6-BFD0-9BEC9DBBD728Q36438937-FAA10D9D-1FB7-4E92-A2DC-9F3ADDBDD9A3Q36456613-797E20B1-EFBB-4908-AF48-97D94F4729E5Q37579184-5334A00D-1BFB-4FAB-8D83-74E867288E93Q40061790-9B2E1F4A-1240-47A7-ACD8-1570DE8F0E0EQ40131084-FBCFBBCC-A9D8-493D-9A92-A8AADF59FB51Q40735145-EC518D18-DA40-4A93-B765-ACED5FFD2FC1Q41099994-2C5A76F1-DA0E-4AB6-8B99-3C86A683E92AQ41127343-DF49E859-3ACE-4EA5-89A1-183B5177E8BAQ41559832-75FE77F7-F476-4076-B7A6-558C7654D10DQ41917438-30B3A8AA-E68A-468F-86B6-9A86FD04B98B
P2860
Cefoxitin as an alternative to carbapenems in a murine model of urinary tract infection due to Escherichia coli harboring CTX-M-15-type extended-spectrum β-lactamase.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@ast
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@en
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@nl
type
label
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@ast
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@en
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@nl
prefLabel
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@ast
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@en
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase.
@nl
P2093
P2860
P356
P1476
Cefoxitin as an alternative to ...... extended-spectrum β-lactamase
@en
P2093
Agnès Lefort
Amandine Nucci
Bruno Fantin
Françoise Chau
Laurent Massias
Patrick Le
Raphaël Lepeule
P2860
P304
P356
10.1128/AAC.06233-11
P407
P577
2012-01-03T00:00:00Z